225 results on '"Boules, Mena"'
Search Results
2. Health-Related Quality of Life and Perceived Stigma in Eosinophilic Esophagitis: A Real-World, US, Web-Based Survey
3. Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
4. Satisfaction With and Adherence to Off-Label Corticosteroids in Adolescents and Adults With Eosinophilic Esophagitis
5. S668 Efficacy and Safety of Prucalopride in Patients With Chronic Idiopathic Constipation From Different Racial and Ethnic Groups: A Post Hoc Analysis of Phase 3 and 4 Clinical Study Data
6. Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis
7. Comparative Outcomes of Bariatric Surgery in Patients With and Without Human Immunodeficiency Virus
8. Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply
9. A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation
10. Upper gastrointestinal endoscopy is safe and feasible in the early postoperative period after Roux-en-Y gastric bypass
11. Endoscopic stents in the management of anastomotic complications after foregut surgery: new applications and techniques
12. Factors associated with length of stay in intensive care after bariatric surgery
13. Revisional bariatric surgery can improve refractory metabolic disease
14. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study
15. A Review of the Cardiovascular Safety of Prucalopride in Patients with Chronic Idiopathic Constipation
16. Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 clinical trials
17. Laparoscopic versus open inguinal hernia repair in patients with obesity: an American College of Surgeons NSQIP clinical outcomes analysis
18. Laparoscopic duodenojejunostomy for superior mesenteric artery syndrome: intermediate follow-up results and a review of the literature
19. Primary Inadequate Weight Loss After Roux-en-Y Gastric Bypass Is not Associated with Poor Cardiovascular or Metabolic Outcomes: Experience from a Single Institution
20. S170 Efficacy and Safety of Prucalopride in Patients With Renal Dysfunction: A Post Hoc Analysis of Phase 3 and 4 Clinical Trials in Chronic Idiopathic Constipation
21. Effects of treatment cessation and re‐treatment in randomized controlled trials of prucalopride in patients with chronic idiopathic constipation.
22. Total Weight Loss as the Outcome Measure of Choice After Roux-en-Y Gastric Bypass
23. Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1-3 clinical trials.
24. Pre-operative opioid analgesia reduces clinical success of laparoscopic gastric electrical stimulation placement in patients with gastroparesis
25. Su1173: EFFECT OF PRIOR ESOPHAGEAL DILATION ON HISTOLOGIC, SYMPTOM AND ENDOSCOPIC OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION
26. Tu1336: A REAL-WORLD STUDY OF PERSISTENCE AND ADHERENCE TO PRESCRIPTION MEDICATIONS IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION
27. Tu1345: EFFICACY AND SAFETY OF PRUCALOPRIDE IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION STRATIFIED BY AGE: A POST HOC ANALYSIS OF PHASE 3 AND 4 CLINICAL TRIALS
28. 990: EFFECT OF RANDOMIZED WITHDRAWAL OF BUDESONIDE ORAL SUSPENSION ON EFFICACY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS OF HISTOLOGIC, SYMPTOM AND ENDOSCOPIC OUTCOMES
29. Su1196: EFFECT OF TIME SINCE DIAGNOSIS ON EFFICACY OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POOLED DATA FROM A PHASE 2 AND A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION
30. S520 Healthcare Costs Before and After the Initiation of Prucalopride Treatment: A Real World Study in Patients With Constipation in the US
31. S400 Perceptions of Disease Stigma in Adolescents and Adults With Eosinophilic Esophagitis in the US
32. S390 Estimating the Indirect and Intangible Costs Associated With Eosinophilic Esophagitis
33. S382 Long-Term Safety of Budesonide Oral Suspension for Eosinophilic Esophagitis: An Integrated Safety Analysis of Phase 1–3 Clinical Trial Data
34. S502 Clinical Outcomes Before and After the Initiation of Prucalopride Treatment: A Real World Study in Patients With Constipation in the USA
35. S401 Patient Satisfaction and Adherence to Corticosteroids in Adolescents and Adults With Eosinophilic Esophagitis in a Real-World Setting in the US
36. S528 Healthcare Resource Use Before and After the Initiation of Prucalopride Treatment: A Real World Study in Patients With Constipation in the U.S.
37. S399 Health-Related Quality of Life in in Adolescents and Adults With Eosinophilic Esophagitis in a Real World Setting in the US
38. The incidence of hiatal hernia and technical feasibility of repair during bariatric surgery
39. Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
40. Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysis
41. sj-pdf-1-smo-10.1177_2050312120986733 – Supplemental material for Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis
42. Fr174 TIME TO FIRST DYSPHAGIA SYMPTOM RESPONSE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION
43. Fr197 PHARMACOLOGICAL COSTS FOR THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS IN THE USA
44. Fr175 TREATMENT OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS WITH OR WITHOUT CONCOMITANT THERAPIES: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION
45. safety of topical steroids designed specifically for eosinophilic oesophagitis -new data bring new questions. Authors' reply.
46. Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis
47. Tu1741 EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS STRATIFIED BY ETHNICITY AND RACE: A POOLED ANALYSIS OF DATA FROM GEMINI 1, VARSITY, AND VISIBLE 1
48. Pediatric bowel preparation: Sodium picosulfate, magnesium oxide, citric acid vs polyethylene glycol, a randomized trial
49. Mo1665 POLYP DETECTION AND COLON CLEANSING EFFICACY IN YOUNGER ADULTS (<50 YR) WITH A SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND CITRIC ACID BOWEL PREPARATION: SUBANALYSIS FROM A RANDOMIZED, ASSESSOR-BLINDED STUDY
50. 434 SAFETY AND EFFICACY OF A LOW VOLUME BOWEL PREPARATION IN PATIENTS WITH PRE-EXISTING RENAL DYSFUNCTION: SUBANALYSIS FROM A PHASE 3 STUDY OF READY-TO-DRINK SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND CITRIC ACID PREPARATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.